Editorial (Thematic Issue: Signal Transduction, Targeted Therapy and Cancer: From Bench to Clinics)

oa Editorial (Thematic Issue: Signal Transduction, Targeted Therapy and Cancer: From Bench to Clinics)
By Matilde Y. Follo
Source: Current Pharmaceutical Design, Volume 22, Issue 16, May 2016, p. 2307 - 2308
DOI: https://doi.org/10.2174/1381612822999160311144347
- Available online: 01 May 2016

There is no abstract available.

Article metrics loading...

/content/journals/cpd/10.2174/1381612822999160311144347

2016-05-01

2025-04-13

Full text loading...

/content/journals/cpd/10.2174/1381612822999160311144347

Keyword(s): antithrombotic drugs; bone marrow niche; cancer stem cells; differentiation; gene mutations; hematological diseases; hematopoietic stem cells; inositol phosphatases; myelodysplastic syndromes; Nuclear inositides; splicing factors; targeted therapy

oa Editorial (Thematic Issue: Signal Transduction, Targeted Therapy and Cancer: From Bench to Clinics)